Patents Assigned to BAYER PHARAMA AKTIENGESELLSCHAFT
  • Publication number: 20190262340
    Abstract: The present invention relates to the combination of stimulators of soluble guanylate cyclase (sGC stimulators) with mineralocorticoid receptor antagonists (MR antagonists) and to the use of the combination for the treatment and/or prophylaxis of cardiac and cardiovascular disorders, of renal and cardiorenal disorders, of pulmonary and cardiopulmonary disorders and also for the treatment and/or prophylaxis of fibrotic disorders.
    Type: Application
    Filed: October 5, 2017
    Publication date: August 29, 2019
    Applicant: BAYER PHARAMA AKTIENGESELLSCHAFT
    Inventors: Peter KOLKHOF, Peter SANDNER